Kirkland & Ellis LLP handled the four largest healthcare deals from December 2018 to date, advising Bristol-Myers Squibb, Danaher Corporation, WellCare Health Plans and GlaxoSmithKline plc in matters with a combined value of more than $140 billion.

Kirkland advised Bristol-Myers Squibb on its agreement to acquire Celgene Corporation; represented Danaher in its agreement with General Electric to acquire the BioPharma division of GE Life Sciences; guided WellCare on its merger agreement to combine with Centene Corporation; and advised GlaxoSmithKline on its agreement with Pfizer Inc. to combine their consumer health businesses into a new joint venture.

View our M&A Recent Highlights for more information.

Kirkland Handles Four Largest Healthcare Deals

Kirkland Handles Four Largest Healthcare Deals